NeuroPace Inc (NPCE): Total Assets

Annual figures by period end, from SEC filings.

$105.56M
As of 2025-12-31
$96.99M
As of 2026-06-30
-2.6%
3-year compound annual growth
+13.5%
5-year compound annual growth
$133.56M2020-12-31: $55.95M2021-12-31: $133.56M2022-12-31: $114.11M2023-12-31: $107.65M2024-12-31: $94.65M2025-12-31: $105.56M$105.56M
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$105.56M+11.5%2026-03-03, Balance as of period end
2024-12-31$94.65M-12.1%2026-03-03, Balance as of period end
2023-12-31$107.65M-5.7%2025-03-04, Balance as of period end
2022-12-31$114.11M-14.6%2024-03-05, Balance as of period end
2021-12-31$133.56M+138.7%2023-03-02, Balance as of period end
2020-12-31$55.95Mn/a2022-03-10, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
NeuroPace Inc (NPCE)2025-12-31$105.56M+11.5%
Beta Bionics, Inc. (BBNX)2025-12-31$328.74M+119.7%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$358.46M+21.2%
Pulmonx Corp (LUNG)2025-12-31$129.29M-20.6%
Anika Therapeutics, Inc. (ANIK)2025-12-31$190.27M-6.2%
Orasure Technologies Inc (OSUR)2025-12-31$403.17M-15.9%
Delcath Systems, Inc. (DCTH)2025-12-31$123.63M+61.4%
Iradimed Corp (IRMD)2025-12-31$108.78M+10.6%
TELA Bio, Inc. (TELA)2025-12-31$81.42M-6.0%

Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗